Skip to main content

Market Overview

15 Biotechnology Stocks Moving In Thursday's After-Market Session

Share:

 

Gainers

Alector, Inc. (NASDAQ:ALEC) stock rose 10.8% to $25.79 during Thursday's after-market session. The most recent rating by BTIG, on November 21, is at Buy, with a price target of $28.00.

Therapix Biosciences, Inc. (NASDAQ:TRPX) stock moved upwards by 6.1% to $0.61.

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) shares increased by 5.7% to $2.80. The most recent rating by BMO Capital, on December 09, is at Outperform, with a price target of $8.00.

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) shares surged 5.2% to $4.04. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00.

Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) shares rose 5.1% to $2.25.

Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) stock moved upwards by 5.0% to $0.20.

Heat Biologics, Inc. (NASDAQ:HTBX) stock rose 4.5% to $0.30.

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) shares moved upwards by 4.2% to $3.59. According to the most recent rating by Gabelli & Co., on December 11, the current rating is at Hold.

Viking Therapeutics, Inc. (NASDAQ:VKTX) stock increased by 3.5% to $7.05.

 

Losers

Akero Therapeutics, Inc. (NASDAQ:AKRO) stock fell 6.1% to $23.00 during Thursday's after-market session.

AC Immune, Inc. (NASDAQ:ACIU) shares plummeted 5.1% to $8.78. The most recent rating by H.C. Wainwright, on December 10, is at Buy, with a price target of $11.00.

Aquestive Therapeutics, Inc. (NASDAQ:AQST) stock declined 3.8% to $3.82. The most recent rating by BMO Capital, on January 13, is at Outperform, with a price target of $18.00.

ContraFect, Inc. (NASDAQ:CFRX) shares plummeted 3.6% to $1.08.

Applied Genetic Tech, Inc. (NASDAQ:AGTC) shares fell 3.5% to $8.08.

Verastem, Inc. (NASDAQ:VSTM) shares plummeted 3.1% to $1.88.

 

Related Articles (TRPX + ALEC)

View Comments and Join the Discussion!

Posted-In: biotechnology stocksAfter-Hours Center Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com